Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Divergent Synthesis of Pyrone Diterpenes via Radical Cross Coupling.

Merchant RR, Oberg KM, Lin Y, Novak AJE, Felding J, Baran PS.

J Am Chem Soc. 2018 Jun 20;140(24):7462-7465. doi: 10.1021/jacs.8b04891. Epub 2018 Jun 11.

2.

Divergent synthesis of thapsigargin analogs.

Chu H, Dünstl G, Felding J, Baran PS.

Bioorg Med Chem Lett. 2018 Sep 1;28(16):2705-2707. doi: 10.1016/j.bmcl.2018.03.065. Epub 2018 Mar 23.

3.

Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs.

Parker CG, Kuttruff CA, Galmozzi A, Jørgensen L, Yeh CH, Hermanson DJ, Wang Y, Artola M, McKerrall SJ, Josyln CM, Nørremark B, Dünstl G, Felding J, Saez E, Baran PS, Cravatt BF.

ACS Cent Sci. 2017 Dec 27;3(12):1276-1285. doi: 10.1021/acscentsci.7b00420. Epub 2017 Dec 6.

4.

Scalable Synthesis of (-)-Thapsigargin.

Chu H, Smith JM, Felding J, Baran PS.

ACS Cent Sci. 2017 Jan 25;3(1):47-51. doi: 10.1021/acscentsci.6b00313. Epub 2016 Dec 19.

5.

Nineteen-step total synthesis of (+)-phorbol.

Kawamura S, Chu H, Felding J, Baran PS.

Nature. 2016 Apr 7;532(7597):90-3. doi: 10.1038/nature17153. Epub 2016 Mar 23.

6.

C-H Oxidation of Ingenanes Enables Potent and Selective Protein Kinase C Isoform Activation.

Jin Y, Yeh CH, Kuttruff CA, Jørgensen L, Dünstl G, Felding J, Natarajan SR, Baran PS.

Angew Chem Int Ed Engl. 2015 Nov 16;54(47):14044-8. doi: 10.1002/anie.201507977. Epub 2015 Sep 29.

7.

Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity.

Nilsson N, Felding J.

Future Med Chem. 2015;7(14):1853-9. doi: 10.4155/fmc.15.122. Epub 2015 Sep 22. No abstract available.

8.

Development of a concise synthesis of ouabagenin and hydroxylated corticosteroid analogues.

Renata H, Zhou Q, Dünstl G, Felding J, Merchant RR, Yeh CH, Baran PS.

J Am Chem Soc. 2015 Jan 28;137(3):1330-40. doi: 10.1021/ja512022r. Epub 2015 Jan 16.

9.

Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.

Felding J, Sørensen MD, Poulsen TD, Larsen J, Andersson C, Refer P, Engell K, Ladefoged LG, Thormann T, Vinggaard AM, Hegardt P, Søhoel A, Nielsen SF.

J Med Chem. 2014 Jul 24;57(14):5893-903. doi: 10.1021/jm500378a. Epub 2014 Jul 1. Review.

PMID:
24984230
10.

14-step synthesis of (+)-ingenol from (+)-3-carene.

Jørgensen L, McKerrall SJ, Kuttruff CA, Ungeheuer F, Felding J, Baran PS.

Science. 2013 Aug 23;341(6148):878-82. doi: 10.1126/science.1241606. Epub 2013 Aug 1. Erratum in: Science. 2015 Nov 27;350(6264):aad8935.

11.

Synthesis of enantiopure 3-substituted morpholines.

Bornholdt J, Felding J, Kristensen JL.

J Org Chem. 2010 Nov 5;75(21):7454-7. doi: 10.1021/jo101339g.

PMID:
20879782
12.

Ring opening of pymisyl-protected aziridines with organocuprates.

Bornholdt J, Felding J, Clausen RP, Kristensen JL.

Chemistry. 2010 Nov 2;16(41):12474-80. doi: 10.1002/chem.201001026.

PMID:
20839183
13.

Syntheses and antiproliferative evaluation of oxyphenisatin derivatives.

Uddin MK, Reignier SG, Coulter T, Montalbetti C, Grånäs C, Butcher S, Krog-Jensen C, Felding J.

Bioorg Med Chem Lett. 2007 May 15;17(10):2854-7. Epub 2007 Feb 25.

PMID:
17368900
14.

Recent advances in otitis media. 2. Eustachian tube, middle ear, and mastoid anatomy; physiology, pathophysiology, and pathogenesis.

Bluestone CD, Hebda PA, Alper CM, Sando I, Buchman CA, Stangerup SE, Felding JU, Swarts JD, Ghadiali SN, Takahashi H.

Ann Otol Rhinol Laryngol Suppl. 2005 Jan;194:16-30. Review. No abstract available.

PMID:
15700932
15.

Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.

Lous J, Burton MJ, Felding JU, Ovesen T, Rovers MM, Williamson I.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001801. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD001801.

PMID:
15674886
16.

Emerging classes of protein-protein interaction inhibitors and new tools for their development.

Pagliaro L, Felding J, Audouze K, Nielsen SJ, Terry RB, Krog-Jensen C, Butcher S.

Curr Opin Chem Biol. 2004 Aug;8(4):442-9. Review.

PMID:
15288255
17.

Recent advances in otitis media. 3. Middle ear physiology and pathophysiology.

Alper CM, Bluestone CD, Buchman C, Bunne M, Felding JU, Hebda PA, Hergils L, Honjo I, Luntz M, Sando I, Stangerup SE, Swarts JD, Takahashi H.

Ann Otol Rhinol Laryngol Suppl. 2002 Mar;188:26-35. Review. No abstract available.

PMID:
11968859
18.

Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.

Stensbøl TB, Uhlmann P, Morel S, Eriksen BL, Felding J, Kromann H, Hermit MB, Greenwood JR, Braüner-Osborne H, Madsen U, Junager F, Krogsgaard-Larsen P, Begtrup M, Vedsø P.

J Med Chem. 2002 Jan 3;45(1):19-31.

PMID:
11754576
19.

Effect of N-acetylcysteine on the incidence of recurrence of otitis media with effusion and re-insertion of ventilation tubes.

Ovesen T, Felding JU, Tommerup B, Schousboe LP, Petersen CG.

Acta Otolaryngol Suppl. 2000;543:79-81.

PMID:
10908985
20.

[Language development in secretory otitis media].

Lous J, Ovesen T, Felding JU.

Ugeskr Laeger. 1999 Nov 1;161(44):6063-4. Danish. No abstract available.

PMID:
10778345
21.

[Tympanometry].

Lous J, Hansen JG, Felding JU.

Ugeskr Laeger. 2000 Mar 27;162(13):1908-11. Review. Danish.

PMID:
10765708
22.

[Politics, war between tribes or science?].

Felding JU.

Ugeskr Laeger. 1999 Dec 20;161(51):7119-20. Danish. No abstract available.

PMID:
10647307
23.

A new immunocapture assay for Escherichia coli beta-galactosidase for in vivo studies of lacZ-transduced tumor cells.

Holst-Hansen C, Brünner N, Johannessen BE, Felding J, Stephens RW.

Lab Invest. 1998 Dec;78(12):1643-4. No abstract available.

PMID:
9881965
24.

Middle ear gas--its composition in the normal and in the tubulated ear. A methodological and clinical study.

Felding JU.

Acta Otolaryngol Suppl. 1998;536:1-57. No abstract available.

PMID:
9726702
25.
26.
27.

The biochemical characteristics of the middle ear system measured by a new method. I: Instrumentation.

Felding JU, Gaihede M, Elbrønd E.

Acta Otolaryngol. 1995 May;115(3):408-13.

PMID:
7653263
28.

Preparation of oligodeoxyribonucleoside phosphorodithioates by a triester method.

Eldrup AB, Bjergårde K, Felding J, Kehler J, Dahl O.

Nucleic Acids Res. 1994 May 25;22(10):1797-804.

29.

[Treatment of tubal dysfunction and secretory otitis media with a nasal balloon (Otovent)].

Felding JU, Tommerup BE.

Ugeskr Laeger. 1992 May 25;154(22):1580-3. Danish. No abstract available.

PMID:
1631990
30.
31.

Stapes surgery: complications and airway infection.

Brahe Pedersen C, Felding JU.

Ann Otol Rhinol Laryngol. 1991 Aug;100(8):607-11.

PMID:
1872509
32.
33.

Acoustic rhinometry, used as a method to demonstrate changes in the volume of the nasopharynx after adenoidectomy.

Elbrønd O, Hilberg O, Felding JU, Blegvad Andersen O.

Clin Otolaryngol Allied Sci. 1991 Feb;16(1):84-6.

PMID:
2032366
34.

Human leukocyte antigen-A, -B, -C tissue types in patients with middle ear cholesteatoma.

Felding JU, Pedersen CB, Lamm LU.

Ann Otol Rhinol Laryngol. 1988 Mar-Apr;97(2 Pt 1):192-4.

PMID:
3258487
35.

Reinke's oedema and thyroid function: a prospective study in 43 patients.

Lindeberg H, Felding JU, Søgaard H, Illum P.

Clin Otolaryngol Allied Sci. 1987 Dec;12(6):417-20.

PMID:
3442942
36.

Gas composition of the normal and the ventilated middle ear cavity.

Felding JU, Rasmussen JB, Lildholdt T.

Scand J Clin Lab Invest Suppl. 1987;186:31-41.

PMID:
3110937
37.

The nevoid basal cell carcinoma syndrome. Oto-neurological aspects.

Lindeberg H, Felding JU, Skov J.

J Laryngol Otol. 1986 Oct;100(10):1181-5. No abstract available.

PMID:
3490526
38.
39.

The value of X-ray examination of the paranasal sinuses after epistaxis.

Vimpel T, Felding JU, Bonding P.

J Laryngol Otol. 1985 Mar;99(3):253-7.

PMID:
3973494
40.

[Protruding ears. A retrospective study of 83 patients].

Højslet PE, Felding JU, Knudstrup P.

Ugeskr Laeger. 1983 Feb 28;145(9):656-9. Danish. No abstract available.

PMID:
6857830
41.

[The value of x-ray examination of the paranasal sinuses following epistaxis].

Vimpel T, Felding JU, Bonding P.

Ugeskr Laeger. 1983 Feb 28;145(9):650-2. Danish. No abstract available.

PMID:
6857828
42.

[Severe eepistaxis. Incidence, etiology and treatment].

Vimpel T, Felding JU, Bonding P.

Ugeskr Laeger. 1983 Feb 28;145(9):644-9. Danish. No abstract available.

PMID:
6857827
43.
44.

[Juvenile urethral polyp with prostatic glandular tissue].

Felding JU, Søndergaard G.

Ugeskr Laeger. 1981 Dec 21;143(52):3553-4. Danish. No abstract available.

PMID:
7336518
45.

[Necrotising otitis externa].

Felding JU.

Ugeskr Laeger. 1981 Jun 1;143(23):1463-5. Danish. No abstract available.

PMID:
7281298

Supplemental Content

Loading ...
Support Center